Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Everyone agrees the USRM Kits for adipose stem cell therapy is the Gold Standard! Improved results are the industry assumption when using USRM kits.
The sell bullets (kits) and don’t care who wins the war!
USRM is the best Pure Play in Stem Cell PERIOD!
Record earnings and revenues for the 5th straight qtr!!!!
I attended the ARM Conf. Friday, Saturday and Sunday and was very happy at what I saw and heard. USRM was by far the 800lb. Gorilla in the room and was constantly on the tips of everyone’s tongues. The mood in the Exposition room was very energetic and I was sensitive to the conversations around me. I hears stories of remarkable results and how the Med. Professionals enjoyed going to work each day delivering Stem Cell Therapy using USRM Kits and watching some amazing results. The presentations were very well attended and the Q&A was robust and informative. The Stem Cell Industry has finally arrived. Stem Cells are now Main Stream!
Earnings will be out the week of 3/12/18!!!!!!
(https://regenerativeacademy.com/conference/) Heading to ARP today while in Florida. Expect to find management there to answer some questions. Dr Comella is scheduled to speak and should be interesting.
Dr Comella is the President of the Academy and this is her platform for us. I'm most interested in the general atmosphere there. I went to frequent Cannabis Industry Conferences and was able to see when the Industry became confident of the change in Regulations and Governmental Obstacles. The mood changed around 2015 and you could see it at the events and that is when I invested heavily in "Pure Plays" like Village Farms and Emerald Health. They were Pure plays like USRM is in the Stem Cell market. The profits from those investments are what has allowed me to own a significant amount of USRM between $.023 and .07 and growing. I see much greater potential for the Stem Cell Therapy Industry than Cannabis. ex. Dentistry is just begging to see the regenerative nerve growth potential to replace root canals and saving teeth. USRM investors will get News releases like this almost daily for the next 5-10 years.
I will report back when I get a chance.
FDA supports USRM protocols as standard for industry.
Buy under $.10 and wait for pullback if it goes over, IMO.
Great buy under $.10
Nice and easy, no gaps please.
Not too fast here. Slow and steady
New Investors are clambering now! Be careful not to get hurt in the MKT MKR's attempt to goose it and the n pull it back to fill the higher prints.Just slow and easy pressure.
"USRM is the Gold Standard for Adipose Stem Cell Technology and Therapy"
The Earnings report will be huge!!!!!! Regardless of 60-80% growth or 50-65% profit margins it will start to clear off the 2015 numbers and show consistent and excellent results from a REAL and Block Buster Industry Leader!!!!!
But will still be strong according to customers.
Q4 will include the impacts from Hurricanes in them but from clinics I know that deal with USRM outside of Texas and Florida, sales were strong in Q4.
FDA supports USRM study
Just heard from Clinic Head that USRM techniques and Kits are now considered the "GOLD STANDARD".These guys are on FIRE!!!!!
If the numbers are even as good as last quarters this is wonderful! I want to see the profit margins. They were an unbelievable 64% last qtr. This will be a cash COW if they can improve any more!!!!!!!
FDA LOVES USRM!!!!
USRM Client is doing big Kit Numbers. Must flow through to USRM Blow Out Earnings!!!!IMO.
FDA endorses USRM Therapy!!!!
FDA rules Stem Cell use effective!!!!!!
FDA Director in favor of no Regulation of people's own cells!!!
USRM is the best PURE PLAY STEM CELL THERAPY investment. Growing earnings, growing revenues, zero debt, most experienced. Undervalued at current prices.
Regenexx is a String of clinics that rely on Bone Marrow Stem Cells. The problem with Bone Marrow derived Stem Cells is that they have a VERY high concentration of White Blood Cells. White Blood cells are a big contributor to Inflammation so the idea of healing while promoting inflammation is counter intuitive. Another problem with using Bone Marrow is that its not a fun procedure and there is a limited amount in your body and it doesn't get replaced. I personally want to hold on to all the bone marrow in my body, thank you. Humans generally don't come with a lot of spare parts.
Adipose (Fat) Stem Cells are very low in White Blood cells without sacrificing any of the regenerative properties (MUCH BETTER). One last point, the the founder of Regenexx is considered a bit difficult to deal with. The combination of the use of Bone Marrow derived stem cells and management puts this company on the decline as efficient and service oriented competition grows.IMO
FDA Expects many "Breakthroughs" from Stem Cell Therapy in 2018.
FDA finally legitimizes Stem Cell Therapy with recent approval letter.
FDA Director mulling Board seat at USRM.
FDA concerned with lack of Stem Cell Supply for growing demand.
New FDA Director has had Stem Cell Therapy and getting additional Treatements
Market falls 2000 points and USRM breaks out to the upside!!!!!So when is a Hornet a Fly? When he's lost his stinger...Say bye bye stinger. Even if we close flat I am super happy!
FDA expects great strides in Stem Cell Therapy!!!!!!!
Great news!!! Insight into future ?
http://us-stemcell.com/usrm-seeing-explosive-increase-in-demand-for-stem-cell-therapy/
Don't sell the strong USRM to buy weak Large Cap!!!The next big move in the market is into the secondaries and smaller cap stocks. Its back to a stock pickers market and USRM is the best Pick for 2018!!!
FDA is backing Stem Cells work!!!!